Neoadjuvant SHR-1701 with or Without Chemotherapy in Unresectable Stage III Non-Small-cell Lung Cancer: A Proof-of-concept, Phase 2 Trial
CANCER CELL(2024)
关键词
stage III NSCLC,unresectable NSCLC,surgical conversion,neoadjuvant immunotherapy,bispecific antibody,TGF-beta,PD-L1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要